Note: Ingredients listed on restricted chemical lists
EC/CAS
9004-64-2
Name of the chemical
hydroxypropylcellulose
Concentration
N/A
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
N/A
EC/CAS
14807-96-6
Name of the chemical
Talc
Concentration
N/A
General Information
Revision date
2022-04-20
Product name
TAFENOQUINE DISPERSIBLE 50MG TABLET
Product Synonyms
TAFENOQUINE DISPERSIBLE FILM COATED TABLET * TAFENOQUINE SUCCINATE, FORMULATED PRODUCT
1.2.1 Relevant identified uses
the purpose intended. Consumers/Patients should consult prescribing information/package insert/product label or consult their chemist or physician Specific restrictions for use of No other uses are advised
supplier name
GlaxoSmithKline US
Icons in SDS
Company Information
company name
GlaxoSmithKline US
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Danger
Section 2
Physical hazards
Not classified.
Health hazards
Acute toxicity, oral Category 4 Specific target organ toxicity following Category 1 repeated exposure
Environmental hazards
Hazardous to the aquatic environment, acute Category 1 Hazardous to the aquatic environment, Category 1
Signal word
Danger
Hazard statements
Harmful if swallowed. Causes damage to organs through prolonged or repeated exposure. Very toxic to aquatic life. Very toxic to aquatic life with long lasting effects.
Prevention
Do not breathe dust. Wash thoroughly after handling. Do not eat, drink or smoke when using this product. Avoid release to the environment.
Response
IF SWALLOWED: Call a POISON CENTRE/doctor// if you feel unwell. Rinse mouth. Get medical advice/attention if you feel unwell. Collect spillage.
Storage
Store away from incompatible materials.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations.
Other hazards which do not result in classification
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Additional information
76.664 % of the mixture consists of component(s) of unknown acute oral toxicity. 97.274 % of the mixture consists of component(s) of unknown acute dermal toxicity. 97.274 % of the mixture consists of component(s) of unknown acute inhalation toxicity. 77.874 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 77.874 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment. Contains TAFENOQUINE. May produce an allergic reaction.
